Full text is available at the source.
Targeting immunosenescence in lung diseases: mechanistic insights and clinical interventions
Understanding and treating aging-related immune decline in lung diseases
AI simplified
Abstract
Immunosenescence is associated with the pathogenesis and progression of lung diseases.
- Age-related decline in immune function may contribute to various lung diseases, including COPD, lung cancer, and asthma.
- Current therapeutic strategies evaluated in clinical trials include senolytics, immunotherapy, and stem cell therapy.
- Personalized approaches utilizing multi-omics data and artificial intelligence could enhance biomarker-driven interventions.
- Rigorously designed clinical trials are essential for developing and validating interventions targeting immunosenescence.
AI simplified